StockData
Solventum Corp logo

Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.06−2.59 (-2.92%)

Close on Nov 17, 2026Market cap $14.65BP/E 96.7Yield –

Solventum operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Solventum's operating income for the twelve months ending Sep 30, 2026 was $454.00M, down 79.3% year over year. For fiscal 2025 it was $2.18B, up 110.5% from the year before.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.18B+110.5%
FY2024Dec 31, 2024$1.04B-38.8%
FY2023Dec 31, 2023$1.69B-0.1%
FY2022Dec 31, 2022$1.69B–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$68.00M-96.0%
Q2 FY2026Jun 30, 2026$181.00M-15.4%
Q1 FY2026Mar 31, 2026$81.00M-46.7%
Q4 FY2025Dec 31, 2025$124.00M-8.8%
Q3 FY2025Sep 30, 2025$1.69B+514.5%
Q2 FY2025Jun 30, 2025$214.00M-12.3%
Q1 FY2025Mar 31, 2025$152.00M-60.1%
Q4 FY2024Dec 31, 2024$136.00M-66.5%
Q3 FY2024Sep 30, 2024$275.00M-45.4%
Q2 FY2024Jun 30, 2024$244.00M-41.5%
Q1 FY2024Mar 31, 2024$381.00M+4.4%
Q4 FY2023Dec 31, 2023$406.00M–
Q3 FY2023Sep 30, 2023$504.00M–
Q2 FY2023Jun 30, 2023$417.00M–
Q1 FY2023Mar 31, 2023$365.00M–

More Solventum figures

See a number that looks wrong?